Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Pancreatic Cancer”

1,047 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,047 results

Testing effectiveness (Phase 2)WithdrawnNCT00882765
What this trial is testing

Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Who this might be right for
Pancreatic Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00810953
What this trial is testing

A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy

Who this might be right for
Pancreatic Cancer
Oncozyme Pharma Inc. 10
Testing effectiveness (Phase 2)Study completedNCT00003760
What this trial is testing

Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
The University of Texas Health Science Center at San Antonio 3
Testing effectiveness (Phase 2)WithdrawnNCT00253526
What this trial is testing

Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage I Pancreatic Cancer+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01601808
What this trial is testing

Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma

Who this might be right for
Pancreatic Cancer
University of Liverpool 142
Testing effectiveness (Phase 2)Study completedNCT01838317
What this trial is testing

A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas

Who this might be right for
Cancer of the Pancreas
University of Texas Southwestern Medical Center 14
Not applicableStudy completedNCT00900016
What this trial is testing

Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery

Who this might be right for
Pancreatic Cancer
Fox Chase Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT01303172
What this trial is testing

A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Immodulon Therapeutics Ltd 110
Large-scale testing (Phase 3)Study completedNCT02172976
What this trial is testing

Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma

Who this might be right for
Resectable Prancreas Carcinoma
Krankenhaus Nordwest 40
Testing effectiveness (Phase 2)Ended earlyNCT04390243
What this trial is testing

Binimetinib and Encorafenib for the Treatment of Pancreatic Cancer in Patients With a Somatic BRAF V600E Mutation

Who this might be right for
Locally Advanced Pancreatic CarcinomaMetastatic Pancreatic CarcinomaRecurrent Pancreatic Carcinoma+2 more
Academic and Community Cancer Research United 6
Testing effectiveness (Phase 2)UnknownNCT03779464
What this trial is testing

Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic CancerNab-paclitaxelGemcitabine+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 132
Testing effectiveness (Phase 2)Study completedNCT00587964
What this trial is testing

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

Who this might be right for
Brain MetastasisBladder CancerBreast Cancer+10 more
Memorial Sloan Kettering Cancer Center 51
Testing effectiveness (Phase 2)Ended earlyNCT04212026
What this trial is testing

Irreversible Electroporation (IRE) Followed by Nivolumab in Patients With Metastatic Pancreatic Cancer.

Who this might be right for
Metastatic Pancreatic Cancer
University Hospital, Basel, Switzerland 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390826
What this trial is testing

Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)UnknownNCT06153368
What this trial is testing

Cadonilimab Plus mFOLFIRINOX as Conversion Therapy in LAPC

Who this might be right for
Pancreatic Cancer
The First Affiliated Hospital with Nanjing Medical University 30
Testing effectiveness (Phase 2)WithdrawnNCT03374852
What this trial is testing

CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Sidney Kimmel Cancer Center at Thomas Jefferson University
Testing effectiveness (Phase 2)Study completedNCT00411762
What this trial is testing

A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma

Who this might be right for
Pancreatic Cancer
Yale University 25
Testing effectiveness (Phase 2)Study completedNCT03146962
What this trial is testing

High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies

Who this might be right for
Colorectal CancerPancreatic CancerLung Cancer
Weill Medical College of Cornell University 61
Testing effectiveness (Phase 2)Study completedNCT00041808
What this trial is testing

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Who this might be right for
Metastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more
FeRx 20
Testing effectiveness (Phase 2)Looking for participantsNCT05841420
What this trial is testing

Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer

Who this might be right for
Pancreas CancerNon-Resectable Pancreas Carcinoma
Morten Ladekarl 98
Load More Results